SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rocketman who wrote (1223)6/17/1997 7:37:00 PM
From: Andrew H   of 9719
 
Rman, V1 and other founding fathers and CYTO holders, I am copying my post from the CYTO thread for those who are interested here:

From the AOL board:

>>New employee started at cyto today-Her name is lynn and she comes with very high credentials-her title will vary,VP corprate communications,CFO?--she was a wall street specialist-that has come over from Lilly---News should hopefully be announced.<<

I have heard this is the new CFO but she may have the alternate title of VP of Corporate Communications. In any case, word has it that before she worked at Lilly, she was a biotech analyst for a WS brokerage firm. Like the post says, hopefully we will get the relevant details. This certainly shouldn't hurt the stock.

Also from Puddycat:

>>Check out the internet site for CYTO, talks about Quad and its potential 1 billion dollar sales and about major cancer affiliation with Targon. <<

When we get her name, maybe Biowa will know something about her.
As they say, it take one to know one. An analyst, that is.(:>)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News